Alto Pharmacy Raises $250M in Series D Funding

Alto Pharmacy

Alto Pharmacy, a San Francisco, CA-based digital pharmacy, raised $250M in Series D funding.

The round, which brought total funding raised to date to over $350m, was led by SoftBank Vision Fund 2, , with participation from existing investors, GreenOaks Capital, Jackson Square Ventures, Olive Tree Capital and Zola Global.

The company intends to use the funds to accelerate geographic expansion across the United States and product development.

Co-founded by Matt Gamache-Asselin, CEO, and Jamie Karraker, CTO Alto is digital pharmacy which provides customers with access to medication by scheduling delivery to their home or office the same day, seven days a week. People can also see medication price comparisons, manage their medications, and connect directly with a pharmacist to help them stay on track. Doctors also use the company’s technology to streamline administrative workflows, like benefits investigation and insurance authorizations. Alto currently operates in San Francisco, Los Angeles, Las Vegas, San Diego, Seattle, and Sacramento. It also has offices in Denver.



Join the discussion